Rheumatic Causes for Fever of Unknown OriginJanuary 1, 1970Fever of unknown origin (FUO) represents a diagnostic challenge to many physicians and while cancer…View Resource Not Still’s – Now What?January 1, 1970Your patient doesn’t meet criteria for Still’s disease (AOSD or sJIA), now what should…View Resource JAK Inhibitors in Difficult Still’s DiseaseJanuary 1, 1970A small retrospective study suggests that patients with difficult to treat adult-onset Still’s disease…View Resource Still's disease: paediatrics to adults, a continuum or not?January 1, 1970Still’s disease is a rare inflammatory disorder, affecting less than 1 person per 2000…View Resource Early, Aggressive and Seropositive (7.22.2022)January 1, 1970Dr. Jack Cush covers the news and journal reports from the past week on…View Resource Fever Pitch (7.15.2022)January 1, 1970Dr. Jack Cush reviews the new studies and drug approvals and new insights into…View Resource MRP8/14 as a Biomarker in Systemic Juvenile Idiopathic ArthritisJanuary 1, 1970A large cohort study of children with febrile disorders has demonstrated the diagnostic utility…View Resource Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
Not Still’s – Now What?January 1, 1970Your patient doesn’t meet criteria for Still’s disease (AOSD or sJIA), now what should…View Resource JAK Inhibitors in Difficult Still’s DiseaseJanuary 1, 1970A small retrospective study suggests that patients with difficult to treat adult-onset Still’s disease…View Resource Still's disease: paediatrics to adults, a continuum or not?January 1, 1970Still’s disease is a rare inflammatory disorder, affecting less than 1 person per 2000…View Resource Early, Aggressive and Seropositive (7.22.2022)January 1, 1970Dr. Jack Cush covers the news and journal reports from the past week on…View Resource Fever Pitch (7.15.2022)January 1, 1970Dr. Jack Cush reviews the new studies and drug approvals and new insights into…View Resource MRP8/14 as a Biomarker in Systemic Juvenile Idiopathic ArthritisJanuary 1, 1970A large cohort study of children with febrile disorders has demonstrated the diagnostic utility…View Resource Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
JAK Inhibitors in Difficult Still’s DiseaseJanuary 1, 1970A small retrospective study suggests that patients with difficult to treat adult-onset Still’s disease…View Resource Still's disease: paediatrics to adults, a continuum or not?January 1, 1970Still’s disease is a rare inflammatory disorder, affecting less than 1 person per 2000…View Resource Early, Aggressive and Seropositive (7.22.2022)January 1, 1970Dr. Jack Cush covers the news and journal reports from the past week on…View Resource Fever Pitch (7.15.2022)January 1, 1970Dr. Jack Cush reviews the new studies and drug approvals and new insights into…View Resource MRP8/14 as a Biomarker in Systemic Juvenile Idiopathic ArthritisJanuary 1, 1970A large cohort study of children with febrile disorders has demonstrated the diagnostic utility…View Resource Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
Still's disease: paediatrics to adults, a continuum or not?January 1, 1970Still’s disease is a rare inflammatory disorder, affecting less than 1 person per 2000…View Resource Early, Aggressive and Seropositive (7.22.2022)January 1, 1970Dr. Jack Cush covers the news and journal reports from the past week on…View Resource Fever Pitch (7.15.2022)January 1, 1970Dr. Jack Cush reviews the new studies and drug approvals and new insights into…View Resource MRP8/14 as a Biomarker in Systemic Juvenile Idiopathic ArthritisJanuary 1, 1970A large cohort study of children with febrile disorders has demonstrated the diagnostic utility…View Resource Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
Early, Aggressive and Seropositive (7.22.2022)January 1, 1970Dr. Jack Cush covers the news and journal reports from the past week on…View Resource Fever Pitch (7.15.2022)January 1, 1970Dr. Jack Cush reviews the new studies and drug approvals and new insights into…View Resource MRP8/14 as a Biomarker in Systemic Juvenile Idiopathic ArthritisJanuary 1, 1970A large cohort study of children with febrile disorders has demonstrated the diagnostic utility…View Resource Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
Fever Pitch (7.15.2022)January 1, 1970Dr. Jack Cush reviews the new studies and drug approvals and new insights into…View Resource MRP8/14 as a Biomarker in Systemic Juvenile Idiopathic ArthritisJanuary 1, 1970A large cohort study of children with febrile disorders has demonstrated the diagnostic utility…View Resource Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
MRP8/14 as a Biomarker in Systemic Juvenile Idiopathic ArthritisJanuary 1, 1970A large cohort study of children with febrile disorders has demonstrated the diagnostic utility…View Resource Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
Rheumatic Associated Macrophage Activation SyndromeJanuary 1, 1970Macrophage Activation Syndrome (MAS) is a hyperinflammatory condition that has a significant mortality risk and…View Resource Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
Tocilizumab Works Best in Non-Mechanical Ventilated COVID-19 PatientsJanuary 1, 1970JAMA has published a meta-analysis of 15 studies of hospitalized patients with COVID-19 treated…View Resource Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource 123…45678…91011
Undifferentiated Autoinflammatory Syndrome Called VEXASJanuary 1, 1970Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…View Resource